Newsletters

Winter 2005 Quarterly Newsletter

  • Stem Cell Research in Parkinson's Disease-P.1
  • President’s Message-P.2
  • Stalevo Inital Therapy-P.2
  • Q & A -P.4
  • F.Y.I -P.5-8
  • Executive Functions-P.9
  • Neuroprotection Trials in PD-P.10
  • Music Therapy-P.10
  • FDA Approves Enablex for Treatment of Overactive Bladder-P.11
  • Exelon and Parkinson's Disease-P.12
  • Educational Material-P.12